Evidence map›Paper›PMID 34209812›Full record

ArticleInternational journal of molecular sciences2021

Bifunctional Role of CrkL during Bone Remodeling.

Jung Ha Kim, Kabsun Kim, Inyoung Kim, Semun Seong, Hyun Kook, Kyung Keun Kim, Jeong-Tae Koh, Nacksung Kim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jung Ha KimDepartment of Pharmacology, Chonnam National University Medical School, Gwangju 61469, Korea.ORCID 0000-0003-2543-043X
Kabsun KimDepartment of Pharmacology, Chonnam National University Medical School, Gwangju 61469, Korea.ORCID 0000-0002-8320-5030
Inyoung KimDepartment of Pharmacology, Chonnam National University Medical School, Gwangju 61469, Korea.ORCID 0000-0001-9749-1499
Semun SeongDepartment of Pharmacology, Chonnam National University Medical School, Gwangju 61469, Korea.ORCID 0000-0002-6631-7129
Hyun KookDepartment of Pharmacology, Chonnam National University Medical School, Gwangju 61469, Korea.ORCID 0000-0002-0740-1806
Kyung Keun KimDepartment of Pharmacology, Chonnam National University Medical School, Gwangju 61469, Korea.
Jeong-Tae KohHard-Tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju 61186, Korea.
Nacksung KimDepartment of Pharmacology, Chonnam National University Medical School, Gwangju 61469, Korea.ORCID 0000-0002-8132-3981
Chonnam National University · KR

Funding

National Research Foundation of Korea 2019R1A5A2027521National Research Foundation of Korea 2020R1I1A3067580
6 · The paper itself

Abstract

Coupled signaling between bone-forming osteoblasts and bone-resorbing osteoclasts is crucial to the maintenance of bone homeostasis. We previously reported that v-crk avian sarcoma virus CT10 oncogene homolog-like (CrkL), which belongs to the Crk family of adaptors, inhibits bone morphogenetic protein 2 (BMP2)-mediated osteoblast differentiation, while enhancing receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclast differentiation. In this study, we investigated whether CrkL can also regulate the coupling signals between osteoblasts and osteoclasts, facilitating bone homeostasis. Osteoblastic CrkL strongly decreased RANKL expression through its inhibition of runt-related transcription factor 2 (Runx2) transcription. Reduction in RANKL expression by CrkL in osteoblasts resulted in the inhibition of not only osteoblast-dependent osteoclast differentiation but also osteoclast-dependent osteoblast differentiation, suggesting that CrkL participates in the coupling signals between osteoblasts and osteoclasts via its regulation of RANKL expression. Therefore, CrkL bifunctionally regulates osteoclast differentiation through both a direct and indirect mechanism while it inhibits osteoblast differentiation through its blockade of both BMP2 and RANKL reverse signaling pathways. Collectively, these data suggest that CrkL is involved in bone homeostasis, where it helps to regulate the complex interactions of the osteoblasts, osteoclasts, and their coupling signals.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAnimals, NewbornBone RemodelingCell DifferentiationCells, CulturedHEK293 CellsHumansMiceMice, Inbred ICROsteoblastsOsteoclastsOsteogenesisAdaptor Proteins, Signal TransducingCRKL proteinbone homeostasiscoupling signalCrkLosteoblastosteoclastRANKL

Identifiers

PMID34209812
PMCPMC8269069
OpenAlexW3175188427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.